New Genes Identified as Potential Epilepsy Treatment Targets
This study looked at how genes might influence epilepsy in mice.
This hub covers epilepsy genetics: how gene changes can contribute to seizures (often in children). We translate studies on testing, results like VUS, and what findings may change for care.
No. It’s common in pediatrics, but adults can benefit from genetic testing, too, especially with unclear diagnosis or family history.
Sometimes. For certain conditions, results can guide medication choice, diet therapies, or referral decisions.
It usually means “not enough evidence yet.” It shouldn’t be treated as a definite cause, but it can be reclassified over time.
Not necessarily. Testing can miss some variants, and new gene links are still being discovered.
This study looked at how genes might influence epilepsy in mice.
This study looked at a rare genetic disorder called neuronal ceroid lipofuscinosis type 2 (CLN2 disease) in children in France.
This study looked at how well cenobamate, a medication for epilepsy, works in adults with intellectual disability (ID) compared to those without ID.
Researchers studied different non-invasive neurostimulation treatments for people with drug-resistant epilepsy, which is a type of epilepsy that does not respond well to medications.
Researchers studied children with cerebral palsy (CP) who have more severe movement limitations, classified as GMFCS levels III to V.
Researchers studied the eligibility of infants with genetic epilepsies for a new type of treatment called antisense oligonucleotide therapy.
Researchers studied how juvenile myoclonic epilepsy (JME) affects a person’s ability to understand others’ thoughts and feelings, known as theory of mind (ToM).
This study looked at patients with focal drug-resistant epilepsy who could not have surgery to remove their seizure-causing brain tissue.
Researchers studied the use of whole genome sequencing (WGS) for screening newborns for rare diseases.